gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Long-term PCO evaluation of the AMO Clariflex and Sensar AR40e IOLs with OptiEdge design

Meeting Abstract

  • corresponding author T. M. Rabsilber - Heidelberg Research Group Intraocular Lenses and Refractive Surgery, Department of Ophthalmology, University of Heidelberg, Heidelberg
  • I. J. Limberger - Heidelberg Research Group Intraocular Lenses and Refractive Surgery, Department of Ophthalmology, University of Heidelberg, Heidelberg
  • A. J. Reuland - Heidelberg Research Group Intraocular Lenses and Refractive Surgery, Department of Ophthalmology, University of Heidelberg, Heidelberg
  • B. B. Entz - Heidelberg Research Group Intraocular Lenses and Refractive Surgery, Department of Ophthalmology, University of Heidelberg, Heidelberg
  • G. U. Auffarth - Heidelberg Research Group Intraocular Lenses and Refractive Surgery, Department of Ophthalmology, University of Heidelberg, Heidelberg

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogDO.05.09

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dog2004/04dog050.shtml

Veröffentlicht: 22. September 2004

© 2004 Rabsilber et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective

At the Department of Ophthalmology, Heidelberg, PCO evaluation of a silicone and an acrylic intraocular lens with sharp edge design was performed. Follow-up time ranged between 18 and 24 months.

Methods

In a prospective randomized study either the AMO Clariflex silicone IOL or the Sensar AR40e hydrophobic acrylic IOL was implanted in 47 patients following uneventful phacoemulsification.

Results

Mean patient age was 73.4±12.9 (AR40e) and 76.2±7.8 years (Clariflex), respectively. The IOL power ranged between 10 and 25,5 D. IOL folding and implantation was uneventful. In both groups, all patients achieved an BCVA of 20/32 (AR40e) and 20/25 (Clariflex), respectively. There was a very low PCO development with a mean EPCO score of 0.2 (range between 0 and 0.6), on a scale 0 to 4. Photopic phenomena were not mentioned.

Conclusions

Both IOLs with sharp edge design showed good functional results, a stable position in the capsular bag as well as low PCO development.